Clinical Trials Logo

Ichthyosis Vulgaris clinical trials

View clinical trials related to Ichthyosis Vulgaris.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03173547 Completed - Ichthyosis Vulgaris Clinical Trials

A Six Week Topical Cream Study for Subjects With Ichthyosis Vulgaris

Start date: April 25, 2017
Phase: Phase 2
Study type: Interventional

The objective of this study is to determine and compare the safety and efficacy of topical 146-9251 cream and vehicle cream applied twice daily for 6 weeks in subjects with moderate to severe ichthyosis vulgaris (IV).

NCT ID: NCT01016106 Completed - Atopic Dermatitis Clinical Trials

Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population

Start date: June 2010
Phase: N/A
Study type: Interventional

The investigators' primary objective is to identify common and rare mutations in the filaggrin gene in African American patients with a diagnosis of atopic dermatitis and ichthyosis vulgaris. Atopic dermatitis, or eczema, is a common, chronic, relapsing and remitting problem in many children and affects 10-20% of the pediatric population. Itch is a predominant feature of this disease and is quite disruptive to daily activities of life. In addition to itch, it is characterized by markedly dry skin, small red bumps that may have fluid. Ichthyosis vulgaris is characterized by extremely dry, scaly skin with a fine white scale and increased amounts of lines noted on the palms. Filaggrin is a protein that is essential for the skin to function properly as a barrier and found to be mutated in some European patients with ichthyosis vulgaris and atopic dermatitis. This association has not been looked at in the African American population. Genomic DNA (gDNA) will be purified from buccal swabs using commercially available kits and analyzed.